文献速递慢性肾脏病肾小球疾病

原生肾活检组织病理学病变的预后价值:波士顿肾活检队列研究结果

The Prognostic Value of Histopathologic Lesions in Native Kidney Biopsy Specimens: Results from the Boston Kidney Biopsy Cohort Study.
PubMed 文献 · J Am Soc Nephrol · 2018-06-04

该前瞻性观察队列纳入676例在三家三级医院接受原生肾活检的患者,由两位肾脏病理学家对13类组织病理学进行半定量评分,随访中位34.3个月,199例发生肾脏病进展。调整人口学、临床病理诊断和实验室指标后,非纤维化间质炎症、中重度间质纤维化/肾小管萎缩、中重度全球肾小球硬化、中重度动脉硬化及中重度小动脉硬化均与进展独立相关,基于慢性病变的11分慢性化评分每增加1分,进展风险增加19%。

要点

  • 非纤维化间质炎症与进展风险降低独立相关(HR 0.52)。
  • 中重度IF/TA、全球肾小球硬化、动脉及小动脉硬化均独立增加进展风险。
  • 11分慢性化评分每增加1分,进展风险增加19%。

核心结论

  • 在多种肾脏疾病中,肾活检组织病理学病变在调整蛋白尿和eGFR后仍提供独立预后信息。

研究设计与样本

  • 前瞻性观察队列研究,纳入676例在三家三级医院接受原生肾活检的个体。
  • 活检标本由两位经验丰富的肾脏病理学家对13类组织病理学进行半定量评分。
  • 采用比例风险模型检验组织病理学病变与肾脏病进展(eGFR下降≥40%或RRT)的关联。

主要发现

  • 基线平均eGFR为57.5±36.0 ml/min per 1.73 m2,随访中位34.3个月,199例发生肾脏病进展。
  • 调整人口学、临床病理诊断和实验室指标后,非纤维化间质炎症与进展独立相关(HR 0.52;95%CI 0.32-0.83)。
  • 中度和重度 vs 轻微间质纤维化/肾小管萎缩的HR分别为2.14(95%CI 1.24-3.69)和3.42(95%CI 1.99-5.87)。
  • 中度和重度 vs 轻微全球肾小球硬化的HR分别为2.17(95%CI 1.36-3.45)和3.31(95%CI 2.04-5.38)。
  • 中度和重度 vs 轻微动脉硬化的HR分别为1.78(95%CI 1.15-2.74)和1.64(95%CI 1.04-2.60);中度和重度 vs 轻微小动脉硬化的HR分别为1.63(95%CI 1.08-2.46)和2.33(95%CI 1.42-3.83)。

关键数值与推荐

  • 11分慢性化评分基于慢性病变的半定量评估,每增加1分与肾脏病进展风险升高独立相关(HR 1.19;95%CI 1.12-1.27)。

临床怎么用

  • 肾活检组织病理学半定量评估可用于在临床和实验室指标之外识别肾脏病进展高风险患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background Few studies have evaluated whether histopathologic lesions on kidney biopsy provide prognostic information beyond clinical and laboratory data.Methods We enrolled 676 individuals undergoing native kidney biopsy at three tertiary care hospitals into a prospective, observational cohort study. Biopsy specimens were adjudicated for semiquantitative scores in 13 categories of histopathology by two experienced renal pathologists. Proportional hazards models tested the association between histopathologic lesions and risk of kidney disease progression (≥40% eGFR decline or RRT).Results Mean baseline eGFR was 57.5±36.0 ml/min per 1.73 m2 During follow-up (median, 34.3 months), 199 individuals suffered kidney disease progression. After adjustment for demographics, clinicopathologic diagnosis, and laboratory values, the following lesions (hazard ratio; 95% confidence interval) were independently associated with progression: inflammation in nonfibrosed interstitium (0.52; 0.32 to 0.83), moderate and severe versus minimal interstitial fibrosis/tubular atrophy (2.14; 1.24 to 3.69 and 3.42; 1.99 to 5.87, respectively), moderate and severe versus minimal global glomerulosclerosis (2.17; 1.36 to 3.45 and 3.31; 2.04 to 5.38, respectively), moderate and severe versus minimal arterial sclerosis (1.78; 1.15 to 2.74 and 1.64; 1.04 to 2.60, respectively), and moderate and severe versus minimal arteriolar sclerosis (1.63; 1.08 to 2.46 and 2.33; 1.42 to 3.83, respectively). An 11-point chronicity score derived from semiquantitative assessments of chronic lesions independently associated with higher risk of kidney disease progression (hazard ratio per one-point increase, 1.19; 95% confidence interval, 1.12 to 1.27).Conclusions Across a diverse group of kidney diseases, histopathologic lesions on kidney biopsy provide prognostic information, even after adjustment for proteinuria and eGFR.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Srivastava A, Palsson R, Kaze AD, et al. The Prognostic Value of Histopathologic Lesions in Native Kidney Biopsy Specimens: Results from the Boston Kidney Biopsy Cohort Study. J Am Soc Nephrol. 2018. PMID: 29866798. doi:10.1681/ASN.2017121260

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。